Borland-Groover Clinic

Jacksonville, Florida 33256

0 studies enrolling now · 67 studies all time

What they study most

Barrett Esophagus, Biliary Stricture, Biliary Tract, Biliary Tract Neoplasms, Bowel Preparation, Bronchial Neoplasm, Carcinomas/Neoplasms, Cholangiocarcinoma, Chronic Hepatitis C, Chronic Idiopathic Constipation, Chronic Pancreatitis, Clostridium Difficile

Studies at this site

• Extended Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease — Completed
• Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease — Completed
• A Study in Adolescents and Adults With Eosinophilic Esophagitis (EoE) Measuring Histologic Response and Determine if Reduction in Dysphagia is Achieved — Completed
• Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144 — Stopped early
• Tolerability, Safety and Efficacy of a New Frequency of Vibrant Capsule Administration — Stopped early
• A Safety Study of 3 Different Bowel Cleansing Preparations — Completed
• A Safety and Efficacy Study of BLI-1300 Ointment in Symptomatic Perianal Crohn's Disease — Stopped early
• A Registry for Participants With Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment With a Sofosbuvir-Based Regimen Without Interferon for Chronic Hepatitis C Infection — Stopped early
• A Dose Ranging Study Evaluating Efficacy and Safety of NI-03 — Completed
• A Study to Assess Whether Etrolizumab is a Safe and Efficacious Treatment for Participants With Moderately to Severely Active Crohn's Disease — Completed
• A Dose-Ranging Study With Vupanorsen (TRANSLATE-TIMI 70) — Completed
• trūFreeze® Spray Cryotherapy Patient Registry — Completed
• A Trial for New Treatment of Adult Participants With Irritable Bowel Syndrome — Completed
• A Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs) — Stopped early
• Strategies in Maintenance for Patients Receiving Long-term Therapy (S.I.M.P.L.E.) With MMX (Multi-Matrix System) Mesalamine for Ulcerative Colitis (UC) — Completed
• Prevention of Recurrence of Diverticulitis — Completed
• Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative Colitis — Completed
• Evaluation of Efficacy and Safety of Brazikumab (MEDI2070) in Participants With Active, Moderate to Severe Crohn's Disease — Stopped early
• Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection — Completed
• Phase 2a, Dose-ranging Study With PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD) — Completed
• A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Ulcerative Colitis — Completed
• BI 695501 Versus Humira in Patients With Active Crohn's Disease: a Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity — Completed
• A Trial of Percutaneous vs. Endoscopic Drainage of Suspected Klatskin Tumors — Stopped early
• Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Genotype 1 HCV Infection — Completed
• Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Non-Genotype 1 HCV Infection — Completed
• Study to Assess the Efficacy and Safety of Rifaximin Administered BID in the Treatment of Patients With Diarrhea-Associated Irritable Bowel Syndrome — Completed
• Microbiota Restoration Therapy for Recurrent Clostridium Difficile-associated Diarrhea — Completed
• Colon Capsule Endoscopy (CCE) Versus Computed Tomographic Colonography (CTC) in the Identification of Colonic Polyps in a Screening Population. — Completed
• Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease — Stopped early
• A Randomized, Double-blind, Study to Explore the Effect of GED-0301 in Subjects With Active Crohn's Disease — Completed
• Safety and Efficacy of Sofosbuvir + Velpatasvir With or Without Ribavirin in Treatment-Naive Adults With Chronic HCV Infection — Completed
• Gilead Sustained Virologic Response (SVR) Registry — Completed
• SER-109 Versus Placebo to Prevent Recurrent Clostridium Difficile Infection (RCDI) — Completed
• Performance, Efficacy and Safety of Vibrating Capsule in Aiding Constipated Individuals — Completed
• Evolution® Biliary Stent System-Fully Covered — Completed
• Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo — Completed
• Monitoring Disease Activity Using Video Capsule Endoscopy (VCE) in Crohn's Disease (CD) Subjects — Completed
• Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis — Completed
• A Clinical Trial of Natalizumab in Individuals With Moderately to Severely Active Crohn's Disease — Completed
• Safety and Efficacy of Natalizumab in Combination With Remicade in the Treatment of Crohn's Disease — Completed
• A Study To Investigate The Safety And Possible Clinical Benefit Of Multistem(r) In Patients With Moderate To Severe Ulcerative Colitis — Completed
• Open-Label Study of Sofusbuvir+Ribavirin With or Without Peginterferon Alfa-2a in Subjects With Chronic HCV Infection Who Participated in Prior Gilead HCV Studies — Completed
• UNITY 1: A Study of an Investigational Treatment Regimen of Daclatasvir (DCV) + Asunaprevir (ASV) + BMS-791325 in a Fixed Dose Combination (the DCV 3DAA (Direct Acting Antiviral) Regimen) for 12 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Genotype 1 Infection in Non-cirrhotic Subjects — Completed
• UNITY 2: A Study of an Investigational Treatment Regimen of DCV+ASV+BMS-791325 in a Fixed Dose Combination (the DCV 3DAA (Direct Acting Antiviral) Regimen) With or Without RBV for 12 Weeks for the Treatment of Chronic Hepatitis C Virus(HCV)Genotype 1 Infection in Subjects With Compensated Cirrhosis — Completed
• AXIOS Stent & Delivery System Study — Completed
• Evolution® Biliary Stent System Clinical Study — Completed
• A Study of Abatacept in Patients With Active Ulcerative Colitis — Completed
• Evaluation of Proposed EZ2go Complete Bowel Cleansing System — Completed
• A Study of Telaprevir (VX-950), Pegasys and Copegus in Hepatitis C (PROVE3) — Completed
• A Rollover Study for Subjects Participating in the Control Arm of Study VX06-950-106, VX05-950-104 and VX05-950-104EU Whose Plasma Hepatitis C Virus (HCV) Ribonucleic Acid (RNA) Levels Did Not Respond to Therapy — Completed